Don't miss

Replay


LATEST SHOWS

FOCUS

Is French oak under threat?

Read more

ENCORE!

Questions of gender take centre stage at Avignon’s theatre festival

Read more

IN THE PRESS

Street party, not a wake: Croatian football fans welcome home team

Read more

BUSINESS DAILY

UK looks to calm Brexit fears at Farnborough Airshow

Read more

EYE ON AFRICA

Nigeria: Army denies reports of missing soldiers after Boko Haram attacks

Read more

FOCUS

Despite economic blockade and corruption scandals, Qatar prepares for its 2022 World Cup

Read more

ENCORE!

Beatmaker & singer Estère brings her musical melting pot to Afropunk Paris

Read more

THE OBSERVERS

Iran water shortages, street art in Yemen, and more

Read more

TALKING EUROPE

Maltese foreign minister: ‘We need to implement legal paths of migration into Europe’

Read more

US approves first marijuana-derived drug

© AFP/File | Cannabidiol, or CBD, is derived from cannabis plants, but does not cause users to get high The company procudes high cannabidiol (CBD) content cannabis with THC (psychoactive component) content below the Swiss legal limit. KannaSwiss sell medicinal oil and flowers to smoke.

WASHINGTON (AFP) - 

US regulators on Monday approved the first marijuana-derived drug ever to hit the US market, Epidiolex, which will be used to treat two rare and severe forms of childhood epilepsy.

Epidiolex uses purified cannabidiol, or CBD, which is one of more than 80 active compounds in the cannabis plant.

"This is an important medical advance," said US Food and Drug Administration Commissioner Scott Gottlieb.

"But it's also important to note that this is not an approval of marijuana or all of its components. This is the approval of one specific CBD medication for a specific use," he added.

"And it was based on well-controlled clinical trials evaluating the use of this compound in the treatment of a specific condition."

The drug is approved for use against Lennox-Gastaut syndrome and Dravet syndrome in patients two years of age and older, the FDA said.

Both forms of epilepsy cause severe seizures.

An advisory panel to the FDA recommended in April that the drug be approved.

The FDA is not required to follow the advisory panel's advice but usually does.

CBD does not cause intoxication or euphoria. That so-called "high" comes from a different compound in marijuana, known as tetrahydrocannabinol (THC).

© 2018 AFP